In a development that has sent shockwaves through the corridors of Big Pharma and left oncologists weeping with joy (or possibly gin-induced dehydration), British scientists have apparently stumbled upon the Holy Grail of medicine: a universal cancer vaccine. Yes, you read that correctly. The same NHS that can't find a working MRI scanner for love nor money has allegedly cured every single type of cancer in a petri dish.

Dr. Algernon Fitzwilliams-Smythe, a man whose beard contains more wisdom than the entire House of Commons, announced the discovery at a press conference that was equal parts scientific triumph and Monty Python sketch. We've essentially taught the immune system to recognise cancer cells as the tedious, self-replicating nuisances they are,"

he declared, spraying champagne over a bewildered health minister. The vaccine, cunningly named 'Vax-All', appears to work by reprogramming T-cells to hunt down malignant cells like a pack of caffeinated bloodhounds. Early trials on lab mice have been so successful that the rodents are now forming support groups for their newfound immortality.

Of course, the usual suspects are already circling. AstraZeneca has reportedly offered to buy the patent for a song, while the Daily Mail is preparing a splash proclaiming 'MIGRANTS GETTING VACCINE BEFORE PENSIONERS'. But for now, let us bask in the glorious absurdity of it all.

British science, funded by the much-maligned NHS, has done the one thing that global pharmaceutical conglomerates with their billion-dollar R&D budgets have failed to do for decades. They have actually cured cancer. Or at least, they've discovered a vaccine that might cure cancer.

Details are sketchy, but who cares? The headline is written. The gin is flowing.

And somewhere in Whitehall, a civil servant is already drafting the consultation document on how to charge patients for it.